Authors

Amy Starosciak, Miami Cancer InstituteFollow
Felipe De Los Rios La Rosa, Miami Neuroscience InstituteFollow

Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge

Publication Date

4-2019

Presented At:

QCOR 2019 Scientific Sessions

Content Type

Poster

Additional Authors:

Additional authors and institutional affiliations

Citation

Starosciak, Amy and De Los Rios La Rosa, Felipe, "Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge" (2019). All Publications. 3132.
https://scholarlycommons.baptisthealth.net/se-all-publications/3132